Current Vascular Pharmacology
Title: Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]
Volume: 5 Issue: 3
Author(s): Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros
Affiliation:
Keywords: Percutaneous coronary intervention, stents, medical treatment, treatment cost
Export Options
About this article
Cite this article as:
Anna I. Kakafika , Dimitri P. Mikhailidis , Anthony S. Wierzbicki , Asterios Karagiannis and Vasilios G. Athyros , Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?], Current Vascular Pharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157016107781024145
DOI https://dx.doi.org/10.2174/157016107781024145 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Artificial Neural Network Methods Applied to Drug Discovery for Neglected Diseases
Combinatorial Chemistry & High Throughput Screening Marine Lipids and the Bioavailability of <i>Omega</i>-3 Fatty Acids
Current Nutrition & Food Science Non Steroidal Estrogen Antagonists: Current Status and Future Perspectives
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy
Vascular Disease Prevention (Discontinued) Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
Current Drug Targets The Fallacy of the Longevity Elixir: Negligible Senescence May be Achieved, but Not by Using Something Physical
Current Aging Science Antiplatelet and Antileukocyte Effects of Cardiovascular,Immunomodulatory and Chemotherapeutic Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Screening, Evaluation, and Early Management of Acute Aortic Dissection in the ED
Current Cardiology Reviews Ascorbic Acid: An Old Player with a Broad Impact on Body Physiology Including Oxidative Stress Suppression and Immunomodulation: A Review
Mini-Reviews in Medicinal Chemistry Vasopressin Receptor Antagonists in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Sleep Related Disorders in the Elderly: An Overview
Current Respiratory Medicine Reviews Lentinus edodes: A Macrofungus with Pharmacological Activities
Current Medicinal Chemistry Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets Family Psychoeducation in Clinical High Risk and First-Episode Psychosis
Adolescent Psychiatry Novel Pyrazolyl Benzoxazole Conjugates: Design, Synthesis, Molecular Docking Studies and in vitro Anticancer Activities
Letters in Organic Chemistry The Biology and Therapeutic Potential of the DDAH/ADMA Pathway
Current Pharmaceutical Design Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology